Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
12 NauckMAMeierJJ
The money's in the wallet right now
Semaglutide as a potential investigational alternative for HNF1B-MODY: a case study [PMID: 38524636] Laboratory literature summary: Semaglutide as a potential investigational alternative for HNF1B-MODY: a case study
Within the clinical trial setting, retatrutide has been associated with a range of adverse effects, the majority of which are gastrointestinal in nature
US$ 22.61
US$ 20.31
US$ 20.16
US$ 27.57
US$ 22.22
US$ 23.43
US$ 22.76
,aspect=ignore)
US$ 22.05
US$ 21.16
